Inhibition of hepatitis B virus DNA polymerase by 3'-fluorothymidine triphosphate and other modified nucleoside triphosphate analogs. 1990

H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
Institut für Medizinische Virologie, Humboldt-Universität Berlin, German Democratic Republic.

The 3'-fluoromodified nucleotide analogs 3'-fluorothymidine triphosphate (FdTTP), 2',3'-dideoxy-3'-fluoro-5-chlorouridine triphosphate (F-5CldUTP), 2',3'-dideoxy-3'-fluoro-5-ethyluridine triphosphate (F-5EtdUTP), 2',3'-dideoxy-3'-fluorouridine triphosphate (FdUTP), and 2',3'-dideoxy-3'-fluoro-5-fluorouridine triphosphate (F-5FdUTP) as well as 2',3'-dideoxythymidine triphosphate (ddTTP), 2',3'-didehydro-2',3'-dideoxythymidine triphosphate (ddeTTP), 3'-chlorothymidine triphosphate (CldTTP), and 3'-rhodanothymidine triphosphate (SCNdTTP) were tested for their ability to inhibit hepatitis B virus (HBV)-associated DNA polymerase activity in vitro. The ID50 values of the most potent inhibitors were 0.15 microM for FdTTP, 0.2 microM for ddeTTP, 0.45 microM for ddTTP, and 0.8 microM for F-5CldUTP. SCNdTTP, CldTTP, and F-5EtdUTP were less efficient (ID50 = 3-5 microM), and FdUTP and F-5FdUTP were the least efficient inhibitors (ID50 = 25 microM) of the enzyme activity. Kinetic analysis revealed a competitive type of inhibition for FdTTP and ddeTTP. The Ki values were estimated to be 0.04 microM and 0.08 microM, respectively, compared with a Km value for dTTP of about 0.18 microM.

UI MeSH Term Description Entries
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D019384 Nucleic Acid Synthesis Inhibitors Compounds that inhibit cell production of DNA or RNA. DNA Polymerase Inhibitor,DNA Synthesis Inhibitor,DNA Synthesis Inhibitors,Nucleic Acid Synthesis Inhibitor,RNA Synthesis Inhibitor,RNA Synthesis Inhibitors,DNA Polymerase Inhibitors,Inhibitors, DNA Synthesis,Inhibitors, Nucleic Acid Synthesis,Inhibitors, RNA Synthesis,Inhibitor, DNA Polymerase,Inhibitor, DNA Synthesis,Inhibitor, RNA Synthesis,Inhibitors, DNA Polymerase,Polymerase Inhibitor, DNA,Polymerase Inhibitors, DNA,Synthesis Inhibitor, DNA,Synthesis Inhibitor, RNA,Synthesis Inhibitors, DNA,Synthesis Inhibitors, RNA

Related Publications

H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
December 1989, Antiviral research,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
November 2000, Medical microbiology and immunology,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
July 1987, Journal of medical virology,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
April 2003, The Journal of biological chemistry,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
June 1980, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
May 1996, Antiviral research,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
February 1980, Medical microbiology and immunology,
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
November 1996, Hepatology (Baltimore, Md.),
H Meisel, and K Reimer, and M von Janta-Lipinski, and D Bärwolff, and E Matthes
October 2015, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!